FDA inspection
Mitsubishi Tanabe Pharma America, Inc.: FDA inspection ending Oct 15, 2021
FDA inspection 1155136 · Voluntary Action Indicated (VAI) · Jersey City, NJ
Key facts
| Inspection ID | 1155136 |
|---|---|
| Firm | Mitsubishi Tanabe Pharma America, Inc. |
| FEI number | 3003777563 |
| Address | 525 Washington Blvd Ste 400 |
| City | Jersey City |
| State | NJ |
| ZIP | 07310 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Oct 15, 2021 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data